{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:09:09Z","timestamp":1787242149579,"version":"build-2736575974"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Cardiometabolic diseases are chronic conditions arising from the common pathophysiology of metabolic and cardiovascular disorders accompanied by risk factors such as insulin resistance, obesity, type 2 diabetes, metabolic syndrome, and hypertension. In recent years, the relationship between adipokines such as PAI-1 and vaspin and these diseases has attracted increasing interest. PAI-1 increases cardiovascular risks by inhibiting fibrinolysis, and high PAI-1 levels are associated with obesity and insulin resistance. Vaspin, on the other hand, may have an inhibitory effect on the development of type 2 diabetes and metabolic syndrome by increasing insulin sensitivity. Considering the effects of dietary and lifestyle factors on these molecules, PAI-1 and vaspin are thought to have potential as early biomarkers and therapeutic targets. However, conflicting findings in the literature necessitate further research. Alongside lifestyle interventions based on healthy eating and exercise, changes in PAI-1 and vaspin levels show promise as potential biomarkers for the early diagnosis and prevention of cardiometabolic disorders and the development of personalized treatment strategies. Further research is required to better clarify the molecular mechanisms regulating PAI-1 and vaspin and to determine their potential clinical applications in the prevention and management of cardiometabolic diseases.<\/jats:p>","DOI":"10.3389\/fendo.2026.1787458","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:28:23Z","timestamp":1774502903000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The expanding landscape of adipokines: emerging roles of PAI-1 and vaspin in cardiometabolic diseases"],"prefix":"10.3389","volume":"17","author":[{"given":"Sule","family":"Kocabas","sequence":"first","affiliation":[{"name":"Department of Nutrition and Dietetics, School of Health Sciences, Ankara Medipol University","place":["Alt\u0131nda\u011f, Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevin","family":"Sanlier","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, School of Health Sciences, Ankara Medipol University","place":["Alt\u0131nda\u011f, Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02260-4","article-title":"Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective","volume":"29","author":"Valles-Colomer","year":"2023","journal-title":"Nat Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/nu13114176","article-title":"Obesity and cardiometabolic risk factors: from childhood to adulthood","volume":"13","author":"Drozdz","year":"2021","journal-title":"Nutrients"},{"key":"B3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11892-019-1161-2","article-title":"Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors","volume":"19","author":"Jagannathan","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-021-00904-4","article-title":"Life course socioeconomic position and body composition in adulthood: a systematic review and narrative synthesis","volume":"45","author":"Bridger Staatz","year":"2021","journal-title":"Int J Obes (Lond)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae176","article-title":"Socioeconomic status and obesity","volume":"8","author":"Autret","year":"2024","journal-title":"J Endocr Soc"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0642-9","article-title":"Toward a broader response to cardiometabolic disease","volume":"25","author":"Ralston","year":"2019","journal-title":"Nat Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1524555","article-title":"Body and mind: how obesity triggers neuropsychiatric and neurodegenerative disorders","volume":"15","author":"Pirozzi","year":"2025","journal-title":"Front Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.diabet.2007.09.004","article-title":"Adipokines: the missing link between insulin resistance and obesity","volume":"34","author":"Antuna-Puente","year":"2008","journal-title":"Diabetes Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-018-0185-8","article-title":"The role of adipokines in skeletal muscle inflammation and insulin sensitivity","volume":"15","author":"Nicholson","year":"2018","journal-title":"J Inflammation (Lond)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2009.28449C","article-title":"Adiponectin in insulin resistance: lessons from translational research","volume":"91","author":"Ziemke","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13020270","article-title":"Crucial regulatory role of organokines in relation to metabolic changes in non-diabetic obesity","volume":"13","author":"L\u0151rincz","year":"2023","journal-title":"Metabolites"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.622473","article-title":"Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition","volume":"7","author":"Sillen","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000405","article-title":"Coronavirus disease 2019 and cardiometabolic disease","volume":"30","author":"Kim","year":"2022","journal-title":"Cardiol Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01087","article-title":"PAI-1 exacerbates white adipose tissue dysfunction and metabolic dysregulation in high fat diet-induced obesity","volume":"9","author":"Wang","year":"2018","journal-title":"Front Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1758791","article-title":"Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1)","volume":"49","author":"Morrow","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27020334","article-title":"The roles and associated mechanisms of adipokines in development of metabolic syndrome","volume":"27","author":"Kim","year":"2022","journal-title":"Molecules"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052639","article-title":"Adipokines, myokines, and hepatokines: crosstalk and metabolic repercussions","volume":"22","author":"de Oliveira Dos Santos","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s12964-024-01910-5","article-title":"A signaling pathway map of plasminogen activator inhibitor-1 (PAI-1\/SERPINE1): a review of an innovative frontier in molecular aging and cellular senescence","volume":"22","author":"Shaikh","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1146833","article-title":"Super\u201d SERPINs\u2014a stabilizing force against fibrinolysis in thromboinflammatory conditions","volume":"10","author":"Humphreys","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.653655","article-title":"A serpin with a finger in many PAIs: PAI-1's central function in thromboinflammation and cardiovascular disease","volume":"8","author":"Morrow","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2174\/1389450120666190715102510","article-title":"Recognition of plasminogen activator inhibitor type 1 as the primary regulator of fibrinolysis","volume":"20","author":"Urano","year":"2019","journal-title":"Curr Drug Targets"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.20517\/jca.2024.38","article-title":"Role of plasminogen activator inhibitor-1 (PAI-1) in age-related cardiovascular pathophysiology","volume":"5","author":"Khoddam","year":"2025","journal-title":"J Cardiovasc Aging"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1055\/a-2698-4219","article-title":"A contemporary review of plasminogen activator inhibitor type 1: structure, function, genetic architecture, and intracellular\/extracellular roles","volume":"9","author":"Wortley","year":"2025","journal-title":"TH Open"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031482","article-title":"Structural insight into the two-step mechanism of PAI-1 inhibition by small molecule TM5484","volume":"22","author":"Sillen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411538","article-title":"Vascular ageing: mechanisms, risk factors, and treatment strategies","volume":"24","author":"Ya","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197066","article-title":"PAI-1, the plasminogen system, and skeletal muscle","volume":"21","author":"Rahman","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1918761117","article-title":"Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase","volume":"117","author":"Garcia","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1159\/000541234","article-title":"Circadian rhythms in ischemic stroke: from molecular pathways to chronotherapeutic strategies","volume":"88","author":"Deb","year":"2025","journal-title":"Eur Neurol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpab138","article-title":"Plasminogen activator inhibitor-1 and adiponectin are associated with metabolic syndrome components","volume":"35","author":"Vecchiola","year":"2022","journal-title":"Am J Hypertens"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1124353","article-title":"Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes","volume":"14","author":"Yu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105516","article-title":"PAI-1: a major player in the vascular dysfunction in obstructive sleep apnea","volume":"23","author":"Badran","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2025.01.012","article-title":"adiposetissue.org: a knowledge portal integrating clinical and experimental data from human adipose tissue","volume":"37","author":"Zhong","year":"2025","journal-title":"Cell Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25081992","article-title":"Membrane phospholipids and polyphosphates as cofactors and binding molecules of SERPINA12 (vaspin)","volume":"25","author":"Tindall","year":"2020","journal-title":"Molecules"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071710","article-title":"Review: vaspin (SERPINA12) expression and function in endocrine cells","volume":"10","author":"Kurowska","year":"2021","journal-title":"Cells"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2018_241","article-title":"Molecular mechanisms of vaspin action - from adipose tissue to skin and bone, from blood vessels to the brain","volume":"1111","author":"Weiner","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30252","article-title":"Contribution of organokines in the development of NAFLD\/NASH associated hepatocellular carcinoma","volume":"123","author":"Vachher","year":"2022","journal-title":"J Cell Biochem"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081770","article-title":"Role of omentin, vaspin, cardiotrophin-1, TWEAK and NOV\/CCN3 in obesity and diabetes development","volume":"18","author":"Escot\u00e9","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2018-0108","article-title":"Kallikrein-related peptidase 14 is the second KLK protease targeted by the serpin vaspin","volume":"399","author":"Ulbricht","year":"2018","journal-title":"Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.gene.2017.03.005","article-title":"HSPA5 gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum","volume":"618","author":"Wang","year":"2017","journal-title":"Gene"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.10.055","article-title":"Cell surface GRP78: an emerging imaging marker and therapeutic target for cancer","volume":"328","author":"Farshbaf","year":"2020","journal-title":"J Control Release"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13123040","article-title":"From adipose tissue to endothelial cells\u2014pleiotropic role of vaspin in pathogenesis of metabolic and cardiovascular diseases","volume":"13","author":"D\u0105browski","year":"2025","journal-title":"Biomedicines"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-66950-y","article-title":"Inhibition of adipocyte lipolysis by vaspin impairs thermoregulation in vivo","volume":"16","author":"Rap\u00f6hn","year":"2025","journal-title":"Nat Commun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cca.2021.01.009","article-title":"Adipokines in vascular calcification","volume":"516","author":"Xiao","year":"2021","journal-title":"Clin Chim Acta"},{"key":"B46","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41419-020-2602-1","article-title":"Molecular mechanisms of methylglyoxal-induced aortic endothelial dysfunction in human vascular endothelial cells","volume":"11","author":"Lee","year":"2020","journal-title":"Cell Death Dis"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2021.6.02","article-title":"New insights into cell apoptosis and proliferation: the potential role of vaspin","volume":"72","author":"Pich","year":"2021","journal-title":"J Physiol Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.smhs.2022.01.001","article-title":"Exercise training modulates adipokine dysregulations in metabolic syndrome","volume":"4","author":"Babaei","year":"2022","journal-title":"Sports Med Health Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179399","article-title":"A review of animal models for studying bone health in type-2 diabetes mellitus (T2DM) and obesity","volume":"25","author":"Norazman","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061732","article-title":"Anti-atherogenic effects of vaspin on human aortic smooth muscle cell\/macrophage responses and hyperlipidemic mouse plaque phenotype","volume":"19","author":"Sato","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2016.24","article-title":"Central administration of vaspin inhibits glucose production and augments hepatic insulin signaling in high-fat-diet-fed rat","volume":"40","author":"Luo","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189722","article-title":"Effects of vaspin on pancreatic \u03b2 cell secretion via PI3K\/Akt and NF-\u03baB signaling pathways","volume":"12","author":"Liu","year":"2017","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-022-01091-0","article-title":"Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment","volume":"16","author":"Zhao","year":"2023","journal-title":"J Ovarian Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12978-021-01073-3","article-title":"Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies","volume":"18","author":"Merviel","year":"2021","journal-title":"Reprod Health"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s41745-023-00391-8","article-title":"Inflammatory overtones of organokines in metabolic syndrome and type 2 diabetes","volume":"103","author":"Guria","year":"2023","journal-title":"J Indian Inst Sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13090979","article-title":"The role of organokines in obesity and type 2 diabetes and their functions as molecular transducers of nutrition and exercise","volume":"13","author":"Lim","year":"2023","journal-title":"Metabolites"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004918","article-title":"Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease","volume":"6","author":"Song","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117404","article-title":"Specific inhibition of plasminogen activator inhibitor 1 reduces blood glucose level by lowering TNF-a","volume":"246","author":"Tang","year":"2020","journal-title":"Life Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267833","article-title":"The role of the platelet pool of plasminogen activator inhibitor-1 in well-controlled type 2 diabetes patients","volume":"17","author":"Mossberg","year":"2022","journal-title":"PloS One"},{"key":"B60","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.atherosclerosis.2022.06.705","article-title":"Plasminogen activator inhibitor-1 level associated with the components of metabolic syndrome in a 4G\/5G polymorphism dependent manner","volume":"355","author":"Lo\u030brincz","year":"2022","journal-title":"Atherosclerosis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytox.2022.100064","article-title":"Plasminogen activator inhibitor-1 mediate downregulation of adiponectin in type 2 diabetes patients with metabolic syndrome","volume":"4","author":"Nawaz","year":"2022","journal-title":"Cytokine X"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23112","article-title":"Inhibition of PAI-1 promotes lipolysis and enhances weight loss in obese mice","volume":"29","author":"Levine","year":"2021","journal-title":"Obesity"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.54548\/njps.v36i2.3","article-title":"Glycated haemogloin, fasting plasma glucose, plasminogen activator inhibitor type-1, and soluble thrombomodulin levels in patients with type 2 diabetes mellitus","volume":"36","author":"Akwiwu","year":"2021","journal-title":"Niger J Physiol Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15701","article-title":"Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism","volume":"20","author":"Frischmuth","year":"2022","journal-title":"J Thromb Haemost"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063170","article-title":"PAI-1 in diabetes: pathophysiology and role as a therapeutic target","volume":"22","author":"Altalhi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2019.6.01","article-title":"Oxidative stress and inflammatory markers in prediabetes and diabetes","volume":"70","author":"Luc","year":"2019","journal-title":"J Physiol Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00018-022-04286-2","article-title":"Adipokines, adiposity, and atherosclerosis","volume":"79","author":"Liu","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.578966","article-title":"Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases","volume":"11","author":"Recinella","year":"2020","journal-title":"Front Physiol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/JOE-18-0528","article-title":"Vaspin promotes insulin sensitivity in elderly muscle and is upregulated in obesity","volume":"241","author":"Nicholson","year":"2019","journal-title":"J Endocrinol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1530\/JOE-20-0550","article-title":"Vaspin, a novel adipokine in woman granulosa cells physiology and PCOS pathogenesis","volume":"249","author":"Bongrani","year":"2021","journal-title":"J Endocrinol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1089\/met.2017.0133","article-title":"The association between serum vaspin and omentin-1 levels in obese children with metabolic syndrome","volume":"16","author":"Buyukinan","year":"2018","journal-title":"Metab Syndr Relat Disord"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2022-001989","article-title":"Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes","volume":"9","author":"DiNicolantonio","year":"2022","journal-title":"Open Heart"},{"key":"B73","doi-asserted-by":"publisher","first-page":"13542","DOI":"10.1038\/s41598-018-31923-3","article-title":"Effects of vaspin on insulin resistance in rats and underlying mechanisms","volume":"8","author":"Liu","year":"2018","journal-title":"Sci Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.37.7.4330","article-title":"Correlation of serum vaspin, omentin-1, and adiponectin with metabolic phenotypes in type-2 diabetes mellitus patients","volume":"37","author":"Baig","year":"2021","journal-title":"Pak J Med Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13075-021-02499-7","article-title":"Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study","volume":"23","author":"Rueda-Gotor","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B76","doi-asserted-by":"publisher","first-page":"479","DOI":"10.21037\/atm.2020.03.29","article-title":"Plasma vaspin is an effective biomarker for evaluation of future cardiovascular events in patients with chest pain: a 5-year retrospective observational study","volume":"8","author":"Ji","year":"2020","journal-title":"Ann Transl Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/bab.1850","article-title":"Association of vaspin gene expression and its serum level on the risk of ischemic stroke in type 2 diabetic Egyptian patients: prospective case-control study","volume":"67","author":"Rashad","year":"2020","journal-title":"Biotechnol Appl Biochem"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413529","article-title":"The role of anti-inflammatory adipokines in cardiometabolic disorders: moving beyond adiponectin","volume":"22","author":"Jung","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2016.05.002","article-title":"The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels","volume":"30","author":"Barnard","year":"2016","journal-title":"Blood Rev"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9596054","article-title":"Plasminogen activator inhibitor-1 level correlates with lipoprotein subfractions in obese nondiabetic subjects","volume":"2018","author":"Somodi","year":"2018","journal-title":"Int J Endocrinol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.313775","article-title":"Drug targeting of plasminogen activator inhibitor-1 inhibits metabolic dysfunction and atherosclerosis in a murine model of metabolic syndrome","volume":"40","author":"Khoukaz","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41598-020-79948-x","article-title":"Role of PAI-1 in hepatic steatosis and dyslipidemia","volume":"11","author":"Levine","year":"2021","journal-title":"Sci Rep"},{"key":"B83","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11845-020-02272-w","article-title":"Apelin, omentin-1, and vaspin in patients with essential hypertension: association of adipokines with trace elements, inflammatory cytokines, and oxidative damage markers","volume":"190","author":"Serinkan Cinemre","year":"2021","journal-title":"Ir J Med Sci"},{"key":"B84","doi-asserted-by":"publisher","first-page":"194","DOI":"10.7762\/cnr.2022.11.3.194","article-title":"Evaluation of serum omentin-1, vaspin, leptin, adiponectin levels in obese\/overweight children and their relationship with non-alcoholic fatty liver disease","volume":"11","author":"\u00d6zkan","year":"2022","journal-title":"Clin Nutr Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.14131","article-title":"Efficacy and mechanisms of action of oxytocin in NA\/STZ-induced diabetic Wistar rats: roles of adipocytokines, PI3K\/AKT, and AMPK signaling pathways","volume":"39","author":"Ali","year":"2025","journal-title":"In Vivo"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6507.20.03158-2","article-title":"The evaluation of the role of BMI and insulin resistance on inflammatory markers, PAI-1 levels and arterial stiffness in newly diagnosed type 2 diabetes mellitus patients","volume":"46","author":"Koca","year":"2021","journal-title":"Minerva Endocrinol (Torino)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250090","article-title":"Plasminogen activator inhibitor-1 in poorly controlled vs well controlled type-2 diabetes mellitus patients: a case-control study in a district hospital in Ghana","volume":"16","author":"Nkansah","year":"2021","journal-title":"PloS One"},{"key":"B88","doi-asserted-by":"publisher","first-page":"47","DOI":"10.14710\/jbtr.v9i2.16293","article-title":"Increased level of the plasminogen activator inhibitor type-1 is associated with severity of NAFLD","volume":"9","author":"Indiarso","year":"2023","journal-title":"J BioMed Transl Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1041383","article-title":"siMS score- method for quantification of metabolic syndrome, confirms co-founding factors of metabolic syndrome","volume":"13","author":"Dimitrijevic-Sreckovic","year":"2023","journal-title":"Front Genet"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4103\/azmj.azmj_22_24","article-title":"Plasma plasminogen activator inhibitor-1 as a predictive marker of type 2 diabetic nephropathy in Egyptian patients","volume":"21","author":"El-Saeid","year":"2023","journal-title":"AIMJ"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12061222","article-title":"HOMA-IR as a predictor of PAI-1 levels in women with severe obesity","volume":"12","author":"Martins Kattah","year":"2024","journal-title":"Biomedicines"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14141569","article-title":"Impact of obesity on target organ damage in patients with metabolic syndrome","volume":"14","author":"Kosti\u0107","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"B93","doi-asserted-by":"publisher","first-page":"494","DOI":"10.26574\/maedica.2024.19.3.494","article-title":"Association of adipokines and CIMT in metabolic syndrome in Western Uttar Pradesh population: a cross-sectional study","volume":"19","author":"Singh","year":"2024","journal-title":"Maedica (Bucur)"},{"key":"B94","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13098-025-01629-4","article-title":"Elevated levels of PAI-1 precede the occurrence of type 2 diabetes mellitus","volume":"17","author":"Hernest\u00e5l-Boman","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"B95","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3760\/cma.j.issn.1007-3418.2018.01.009","article-title":"Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial","volume":"26","author":"Jia","year":"2018","journal-title":"Chin J Hepatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/diseases6010009","article-title":"Rosuvastatin improves vaspin serum levels in obese patients with acute coronary syndrome","volume":"6","author":"Al-Kuraishy","year":"2018","journal-title":"Diseases"},{"key":"B97","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12902-020-00648-8","article-title":"Association of adipocytokines with lipid and glycemic profiles in women with normal weight obesity","volume":"20","author":"Taheri","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232483","article-title":"The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro","volume":"15","author":"Kastl","year":"2020","journal-title":"PloS One"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.31782\/IJCRR.2020.12053","article-title":"Correlation of serum vaspin with cardiovascular risk factors in T2DM","volume":"12","author":"Kumari","year":"2020","journal-title":"IJCRR"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13385","article-title":"Serum vaspin levels are positively associated with diabetic retinopathy in patients with type 2 diabetes mellitus","volume":"12","author":"Yang","year":"2021","journal-title":"J Diabetes Investig"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155364","article-title":"Omentin-1 and vaspin serum levels in patients with pre-clinical carotid atherosclerosis and the effect of statin therapy on them","volume":"138","author":"Kadoglou","year":"2021","journal-title":"Cytokine"},{"key":"B102","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21303\/2504-5679.2021.001585","article-title":"Prediction of progression of atherosclerosis in patients with type 2 diabetes mellitus and chronic pancreatitis","volume":"1","author":"Pylov","year":"2021","journal-title":"Eureka Health Sci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.53350\/pjmhs22166741","article-title":"Evaluation of the role of vaspin and insulin resistance in metabolic syndrome","volume":"16","author":"Hameed","year":"2022","journal-title":"Pak J Med Sci"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/biom13030508","article-title":"Association of serum vaspin concentration with metabolic disorders in obese individuals","volume":"13","author":"Pilarski","year":"2023","journal-title":"Biomolecules"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-99-1659-7_67","article-title":"Vaspin levels and diabetic nephropathy in elderly patients with type 2 diabetes mellitus","volume":"96","author":"Mousa","year":"2024","journal-title":"Egypt J Hosp Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980013002115","article-title":"Designing and developing a literature-derived, population-based dietary inflammatory index","volume":"17","author":"Shivappa","year":"2014","journal-title":"Public Health Nutr"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3102870","article-title":"Assessment of dietary patterns represents a potential, yet variable, measure of inflammatory status: a review and update","volume":"2019","author":"Calle","year":"2019","journal-title":"Dis Markers"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nutrit\/nuaf213","article-title":"Mediterranean diet reduces inflammation in adults: a systematic review and meta-analysis of randomized controlled trials","author":"Keshani","year":"2025","journal-title":"Nutr Rev"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2020.1734911","article-title":"Dietary inflammatory potential, cardiometabolic risk and inflammation in children and adolescents: a systematic review","volume":"61","author":"Suhett","year":"2021","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1429883","article-title":"The association between energy-adjusted dietary inflammatory index and metabolic syndrome and its mediatory role for cardiometabolic diseases: a prospective cohort study","volume":"11","author":"Pourmontaseri","year":"2024","journal-title":"Front Nutr"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14579","article-title":"The mediatory role of inflammatory markers on the relationship between dietary energy density and body composition among obese and overweight adult women: a cross-sectional study","volume":"75","author":"Bahrampour","year":"2021","journal-title":"Int J Clin Pract"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/nxaa137","article-title":"The type and amount of dietary fat affect plasma factor VIIc, fibrinogen, and PAI-1 in healthy individuals and individuals at high cardiovascular disease risk: 2 randomized controlled trials","volume":"150","author":"Kris-Etherton","year":"2020","journal-title":"J Nutr"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2016.08.026","article-title":"Effects of exchanging carbohydrate or monounsaturated fat with saturated fat on inflammatory and thrombogenic responses in subjects with abdominal obesity: a randomized controlled trial","volume":"36","author":"Teng","year":"2017","journal-title":"Clin Nutr"},{"key":"B114","doi-asserted-by":"publisher","first-page":"2514850","DOI":"10.1155\/2022\/2514850","article-title":"Mediatory effect of inflammatory markers (IL\u20101B and PAI\u20101) on association of dietary total antioxidant capacity and body composition in overweight and obese women: a cross\u2010sectional study","volume":"1","author":"Radkhah","year":"2022","journal-title":"Int J Clin Pract"},{"key":"B115","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s41043-023-00376-4","article-title":"Inflammatory biomarkers in overweight and obese Iranian women are associated with polyphenol intake","volume":"42","author":"Shiraseb","year":"2023","journal-title":"J Health Popul Nutr"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110978","article-title":"Longitudinal associations of physical activity with inflammatory markers in US adults with and without type 1 diabetes","volume":"206","author":"Richardson","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2024.107071","article-title":"Increased plasminogen activator inhibitor-1 (PAI-1) and its associations with metabolic risk in healthy young adults with early life stress","volume":"166","author":"Kudinova","year":"2024","journal-title":"Psychoneuroendocrinology"},{"key":"B118","doi-asserted-by":"publisher","first-page":"64","DOI":"10.25259\/Cytojournal_141_2024","article-title":"Vaspin inhibits ferroptosis: a new hope for treating myocardial ischemia-reperfusion injury","volume":"21","author":"Lin","year":"2024","journal-title":"Cytojournal"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/nu15245058","article-title":"A Mediterranean eating pattern combining energy and time-restricted eating improves vaspin and omentin concentrations compared to intermittent fasting in overweight individuals","volume":"15","author":"Karras","year":"2023","journal-title":"Nutrients"},{"key":"B120","doi-asserted-by":"publisher","first-page":"699","DOI":"10.21608\/zumj.2019.10713.11170","article-title":"Effect of diet regimen on serum vaspin level in obese diabetic female patients","volume":"25","author":"Mansour","year":"2019","journal-title":"Zagazig Univ Med J"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3390\/nu16213646","article-title":"The effect of a multidisciplinary lifestyle intervention program on Apelin-12, vaspin and resistin concentrations in children and adolescents with overweight and obesity","volume":"16","author":"Karampatsou","year":"2024","journal-title":"Nutrients"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.2337\/db19-733-P","article-title":"Circulating vaspin level was changed with endothelial function, but not with visceral or ectopic fat during lifestyle modification in Korean type 2 diabetes","volume":"68","author":"Han","year":"2019","journal-title":"Diabetes"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-020-04977-4","article-title":"Bariatric surgery in nonalcoholic fatty liver disease (NAFLD): impact assessment using paired liver biopsy and fibroscan","volume":"31","author":"Agarwal","year":"2021","journal-title":"Obes Surg"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12567","article-title":"Benefits and risks of bariatric surgery in adults: a review","volume":"324","author":"Arterburn","year":"2020","journal-title":"JAMA"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-023-06743-8","article-title":"Beneficial short-term effects of bariatric surgery on nutritional inflammatory profile and metabolic biomarkers","volume":"33","author":"Seva","year":"2023","journal-title":"Obes Surg"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2024.103032","article-title":"Metabolic changes induced by bariatric surgery may be mediated by PAI-1 and PCSK9 crosstalk","volume":"55","author":"Castro-Leyva","year":"2024","journal-title":"Arch Med Res"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007498","article-title":"Serum vaspin level as a predictive indicator in the amelioration of fatty liver and metabolic disturbance in patients with severe obesity after laparoscopic vertical banded gastroplasty","volume":"96","author":"Wang","year":"2017","journal-title":"Med (Baltimore)"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00943","article-title":"Inhibition of plasminogen activator inhibitor-1 activation suppresses high fat diet-induced weight gain via alleviation of hypothalamic leptin resistance","volume":"11","author":"Hosaka","year":"2020","journal-title":"Front Pharmacol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-023-00527-y","article-title":"Update on the obesity epidemic: after the sudden rise, is the upward trajectory beginning to flatten","volume":"12","author":"Koliaki","year":"2023","journal-title":"Curr Obes Rep"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3233\/CH-232077","article-title":"Adipokine vaspin maintains angiogenesis and neurological function during cerebral ischemia-reperfusion via suppressing endoplasmic reticulum stress","volume":"87","author":"Yan","year":"2024","journal-title":"Clin Hemorheol Microcirc"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-1488","article-title":"Vaspin: a novel biomarker linking gluteofemoral body fat and type 2 diabetes risk","volume":"47","author":"Wang","year":"2024","journal-title":"Diabetes Care"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1787458\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:29:06Z","timestamp":1774502946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1787458\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":131,"alternative-id":["10.3389\/fendo.2026.1787458"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1787458","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"article-number":"1787458"}}